403 - Forbidden: Access is denied.

- optionforsclc-hcp.com
Not Applicable $ 8.95


403 - Forbidden: Access is denied.

- sclctreatmentoption.com
Not Applicable $ 8.95

OPDIVO® (nivolumab) | Metastatic NSCLC | Healthcare Professionals Hom

- metastaticnsclc-hcp.com

OPDIVO® (nivolumab), for patients with previously treated metastatic non-small cell lung cancer (NSCLC). See Indication and Important Safety Information.

Not Applicable $ 8.95

OPDIVO® (nivolimab) | Relapsed or Progressed cHL after auto-HSCT

- hcp-classical-hodgkin-lymphoma.com

OPDIVO® (nivolumab), for the treatment of patients with classical Hodgkin Lymphoma (cHL) that has relapsed or progressed after autologous HSCT and brentuximab vedotin or after 3 or more lines of systemic therapy that includes autologous HSCT.

Not Applicable $ 8.95

403 - Forbidden: Access is denied.

- opdivoguidepatients.com
Not Applicable $ 8.95

Renal Cell Carcinoma | OPDIVO® (nivolumab) + YERVOY® (ipilimumab) Co

- treatadvancedrcc.com

OPDIVO + YERVOY combination for certain people with kidney cancer that has spread. See Boxed WARNING for YERVOY, Important Safety Information and Indication.

Not Applicable $ 8.95

DNS resolution error | nivolution.com | Cloudflare

- nivolution.com
Not Applicable $ 8.95

DNS resolution error | apixabannewsletter.com | Cloudflare

- apixabannewsletter.com
Not Applicable $ 8.95

EG_HCP_EN_WWREG_LoginPage

- opdivoguide-egsa.com

Immune-related adverse reactions (irARs) that have been reported in association with nivolumab use both in monotherapy and in combination therapy with ipilimumab

Not Applicable $ 8.95

EG_DTC_AR_WWREG_LoginPage

- opdivoguidepatients-egsa.com

Immune-related adverse reactions (irARs) that have been reported in association with nivolumab use both in monotherapy and in combination therapy with ipilimumab

Not Applicable $ 8.95

NULOJIX® (belatacept)-Official Site For US Healthcare Professionals

- nulojixhcp.bmscustomerconnect.com

NULOJIX® (belatacept) official HCP Web site; View Important Safety Information, including Boxed WARNINGS and Full Prescribing Information.

668,938 $ 1,920.00

Fachportal für Onkologie | BMS-Onkologie

- bms-onkologie.de
Not Applicable $ 8.95

Page Not Found

- eliquislt.com
Not Applicable $ 8.95

Page Not Found

- eliquis-rmp-bg.com
Not Applicable $ 8.95

ERROR: The request could not be satisfied

- opdivoyervoymnsclc.com
Not Applicable $ 8.95

Physician and Staff Resources | Rx ELIQUIS® (apixaban)

- eliquis-resources.com

See benefits and risks, including Boxed WARNINGS. Request Rx ELIQUIS® samples and get resources for HCPs and Patients.

Not Applicable $ 8.95

Physician and Staff Resources | Rx ELIQUIS® (apixaban)

- vtepatientresources.com

See benefits and risks, including Boxed WARNINGS. Request Rx ELIQUIS® samples and get resources for HCPs and Patients.

Not Applicable $ 8.95

DNS resolution error | bmsoncologia.com | Cloudflare

- bmsoncologia.com
Not Applicable $ 8.95

DNS resolution error | www.my-multiple-sclerosis.com | Cloudflare

- my-multiple-sclerosis.com
Not Applicable $ 8.95

DNS resolution error | www.my-multiple-sclerosis.org | Cloudflare

- my-multiple-sclerosis.org
Not Applicable $ 8.95


ERROR: The request could not be satisfied

- thesharedregistry.org
Not Applicable $ 8.95